Edition:
India

Invacare Corp (IVC.N)

IVC.N on New York Stock Exchange

17.97USD
22 Feb 2018
Change (% chg)

$-0.28 (-1.53%)
Prev Close
$18.25
Open
$18.30
Day's High
$18.65
Day's Low
$17.88
Volume
27,750
Avg. Vol
80,575
52-wk High
$19.00
52-wk Low
$10.25

Select another date:

BRIEF-Invacare Appoints Kathleen Leneghan CFO

* INVACARE APPOINTS KATHLEEN LENEGHAN CHIEF FINANCIAL OFFICER

BRIEF-Invacare Corp Transfers Küschall Wheelchair Production From Switzerland To France

* INVACARE CORPORATION TRANSFERS KÜSCHALL WHEELCHAIR PRODUCTION FROM SWITZERLAND TO FRANCE

BRIEF-Invacare Corp Reports Q4 Loss Per Share $0.54

* ORATION ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2017

BRIEF-Invacare Says On Jan 3, FDA Notified Co That Its Unit Alber GMBH's Responses To Warning Letter Diclosed In Sept 2017 Are "Adequate" - SEC Filing

* INVACARE SAYS ON JAN 3, FDA NOTIFIED CO THAT ITS UNIT ALBER GMBH'S RESPONSES TO WARNING LETTER DICLOSED IN SEPT 2017 ARE "ADEQUATE" - SEC FILING

BRIEF-Invacare Announces North America Reduction In Force As Part Of Continued Cost Realignment

* INVACARE ANNOUNCES NORTH AMERICA REDUCTION IN FORCE AS PART OF CONTINUED COST REALIGNMENT

BRIEF-Invacare announces departure of Chief Financial Officer

* Invacare Corp - ‍while co performs executive search to identify successor to Gudbranson, Kathleen P. Leneghan will assume role of interim CFO​ Source text for Eikon: Further company coverage:

BRIEF-Invacare says ‍Alber GMBH received warning letter from US food and drug administration​

* Invacare Corp - ‍alber GMBH, a wholly owned subsidiary of Invacare Corporation, received warning letter from United States Food And Drug Administration​

Select another date: